The job requires review of documents related to DMF submission against predefined checklists and submission to various agencies globally.  Should keep the all the regulatory database up to date. Candidate must possess do it right the first-time approach with proven track record. 

Exposure to OSD Manufacturing operations like Granulation, Compression, Coating, Pellet coating, Capsule filling, Primary Packing and Secondary Packing. Expertise in e-BPR and e-log will be added advantage.

M.Sc. in Biotechnology, Biochemistry, Microbiology, M.Tech in Biotechnology from a recognised University. Working experience in Biotechnology, Molecular Biology, yeast biology.

PhD or Masters in Pharmaceutical Sciences, Biochemistry, Biotechnology, or related field with a focus on vaccine development or formulation science.

Good knowledge of Tablet & Capsule, Coating, Granulation, Compression, Good command on QMS & Documentation, IPQA, Qualification. Having good knowledge for scale up, technology transfer and site transfer. Candidates currently in Production and QA may also explore career opportunity in FTT for faster professional growth.

Postgraduate degree in Public Health, Epidemiology, Statistics, Environmental Sciences, Population Sciences, Demography, Health Economics, HTA, Pharmacy with 3 years of post PG experience in research/projects and at least one research paper in SCIE journal

M.Sc, M.Pharm, M.S, M.Tech in Pharmaceutical Chemistry, Medicinal Chemistry, Biotechnology or Equivalent with an exceptionally good academic record with a minimum CGPA of 6.0 on a 10.0 point scale.

PhD in Epidemiology, Environmental Sciences, Health Economics, Health Sciences, Health Technology Assessment, Life Sciences, Pharmacy Practice, Population Sciences, Public Health, Statistics

Any Masters Degree B.E, B.Tech, B.Pharma, MBA, PGD in Management with at least 02 years of experience with having minimum 60% marks OR The candidate should either have a Bachelors degree in science, commerce with at least 03 years of experience with having minimum 60% marks may also attend.

M.Sc in Biotechnology, Biochemistry and any Biological Sciences or M.Tech in any Biological Sciences. The candidates should have qualified for any National Level Eligibility test such as to apply for the above position.

Senior scientist-II will work on isolation, purification of known and unknown impurities/compounds by preparative HPLC and characterization of molecules using various analytical technique and Analytical Method Development for in process samples received from synthetic Lab.

He, she will be responsible for providing Therapeutic Area workstream leads with administrative support on pre-defined projects. The Project Manager will set and develop the operational aspects of the project, develop, and monitor timelines, milestones and project metrics and is responsible for managing the projects from an operational perspective from the development and initiation phases through implementation and completion within scope provided by Medical Directors who remains responsible and accountable for the project content.

To ensure that the products are manufactured and stored as per appropriate documents in order to obtain the required quality. To ensure that the production records are reviewed as per current procedures.

Develop forecasts for focused therapeutic areas using patient-based forecast models, and ensure alignment on forecast assumptions and other critical analytical assessments with client business partners including Marketing, Sales, Market Access and Pricing, Market Research, Global Marketing and Insight, Finance, and Sales Operations

Achieve and exceed the sales targets on a consistent basis through effective implementation of the sales promotion strategies and scientific initiatives. Constantly update the knowledge of disease and product area so as to facilitate scientific discussion with stakeholders to enhance productivity levels as expected by the Company. 

The evidence is clear; individuals should get vaccinated if they have conditions that place them at risk for severe disease. For older adults and those with chronic conditions, RSV should be considered as serious as the flu, and they should get vaccinated

Iterum Therapeutics plc announced that the U.S. Food and Drug Administration has approved Iterums new drug application for ORLYNVAH for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women who have limited or no alternative oral antibacterial treatment options.

B.Pharmacy or B. Sc. and Master degree M.Pharm, M.S. Pharm or M. Sc. in Molecular Biology with minimum of 60% marks from a recognized Indian or Foreign University.